secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001599298-24-000036
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics to present at Barclays Healthcare Conference on March 12
----------------------------------------------------------------------------

- Will present on Tuesday March 12, 2024 at 2:35pm ET.
- Presentation will cover development of investigational bispecific antibody ivonescimab.
- Presenters include CEO Maky Zanganeh, Chairman Robert Duggan, and other executives.
- Live webcast available at www.smmttx.com; archive will be posted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000036/0001599298-24-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000036/smmt-20240305.htm
  HTML page:      https://secwatch.observer/filing/0001599298-24-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer